The pharmacology of aldose reductase inhibitors.
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D000818:Animals; D001485:Basement Membrane / Q000201:enzymology; D001792:Blood Platelets / Q000201:enzymology; D002386:Cataract / Q000201:enzymology / Q000209:etiology; D003315:Cornea / Q000201:enzymology; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000201:enzymology; D003925:Diabetic Angiopathies / Q000201:enzymology; D003928:Diabetic Nephropathies / Q000201:enzymology; D003929:Diabetic Neuropathies / Q000201:enzymology; D003930:Diabetic Retinopathy / Q000201:enzymology; D004912:Erythrocytes / Q000201:enzymology; D006801:Humans; D013401:Sugar Alcohol Dehydrogenases / Q000037:antagonists & inhibitors*; D014882:Water-Electrolyte Balance
D013401:Sugar Alcohol Dehydrogenases; D000449:Aldehyde Reductase